CDSCO License for Blood bank centrifuge
Medical Device Information
Important Notice for Class A Devices
Class A Non-sterile Non Measuring devices are exempt from MD5 and MD15 licenses. Only CDSCO registration is required as per GSR 777(E).
Intended Use
Intended to separate blood components of a suspension by application of centrifugal force.

Comprehensive Guide to CDSCO Licensing for Blood Bank Centrifuge (Class A Medical Device)
As seasoned regulatory consultants with over 25 years of experience and having successfully supported 500+ companies in India, we understand the complexities manufacturers face when obtaining CDSCO licenses. This guide focuses on the Blood Bank Centrifuge, a Class A medical device under the category of General Hospital or Orthopaedic Instruments, notified under 29/Misc./03/2020-DC (193)- Part-3 dated 16.03.2022. We unpack the regulatory framework, license requirements, costs, timelines, and practical tips to help you navigate the process seamlessly.
CDSCO Regulatory Framework for Blood Bank Centrifuge
The Central Drugs Standard Control Organization (CDSCO) governs the import, manufacture, and sale of medical devices in India. As a Class A device, the Blood Bank Centrifuge is considered low risk, and its regulation falls under the State Licensing Authority with specific requirements outlined by CDSCO under the Medical Device Rules (MDR) 2017.
Understanding the regulatory framework is critical to ensure compliance with the latest notifications, including the relevant notification dated 16.03.2022, which explicitly classifies the Blood Bank Centrifuge as a Class A device.
Risk Classification and License Requirements
According to the CDSCO classification, Blood Bank Centrifuge is categorized as Class A (low risk). This classification determines the licensing route and requirements:
- Manufacturing License: MD5 License (Application Form MD3)
- Issuing Authority: State Licensing Authority
- Total Processing Time: Approximately 3-4 months
- Fees: Rs 5,000 per application + Rs 500 per product
For detailed classification information, refer to our Medical Device Classification guide.
Manufacturing License Process (MD5)
The MD5 license is mandatory for manufacturing Blood Bank Centrifuges in India. The step-wise process includes:
- Test License (Form MD13): Before applying for the manufacturing license, obtain a test license valid for 6 months. This typically takes 1.5 to 2 months.
- Product Testing: Conduct product testing at CDSCO-approved government laboratories to verify conformity with Indian standards. Access the list of Testing Laboratories here.
- Document Preparation: Compile all necessary documents, including technical and quality management files.
- Application Submission: Apply for the manufacturing license using Form MD3 through the CDSCO MD Online Portal.
- Audit by Notified Body: A notified body conducts an on-site audit to assess compliance. You can find the list of Notified Bodies here.
- Query Resolution: Address any queries or observations from CDSCO or the notified body.
- License Grant: Upon satisfactory review, the MD5 license is granted.
Manufacturing License Documents Required
For the Blood Bank Centrifuge MD5 license application, ensure you have the following documents ready:
- Company Constitution documents (e.g., Memorandum & Articles of Association)
- Proof of ownership/lease of manufacturing premises
- Details and qualifications of technical staff
- Fire NOC from local fire department
- Pollution Control Board NOC
- Device Master File (DMF) detailing design, specifications, and manufacturing process. Our Device Master File guide offers practical insights.
- Plant Master File (PMF) describing infrastructure and facilities. Learn more from our Plant Master File guide.
- Essential Principles Checklist covering compliance with safety and performance requirements
- Risk Management File outlining hazard analysis and mitigation strategies. Refer to our Risk Management guide.
- Test Reports from CDSCO-approved laboratories
- Product labels and Instructions for Use (IFU)
- Quality Management System (QMS) documents, preferably ISO 13485:2016 certification
Ensuring these documents are comprehensive and well-organized significantly reduces audit queries and expedites approval.
Import License Process (MD15)
For companies importing Blood Bank Centrifuges into India, an MD15 import license from the Central Licensing Authority is mandatory. The process involves:
- Preparation of all required documents (including manufacturing license from the country of origin)
- Application via Form MD14 on the CDSCO MD Online Portal
- Resolution of any queries raised
- Issuance of MD15 license
Note that for Class A devices, this process takes approximately 5-6 months, including document scrutiny and compliance verification.
Import License Documents Required
Key documents for import license application include:
- Valid manufacturing license of the device in the country of origin
- Free Sale Certificate or equivalent
- ISO 13485:2016 certification
- CE Certificate or equivalent international certification
- Device Master File
- Plant Master File
- Wholesale license in India
- Company Constitution documents
Refer to our detailed Import License guide for step-by-step assistance.
Timeline and Processing Duration
License Type | Processing Time |
---|---|
Test License (MD13) | 1.5 to 2 months |
Manufacturing License (MD5) | 3 to 4 months (including audit and query resolution) |
Import License (MD15) | 5 to 6 months |
Planning your project timeline around these benchmarks helps avoid costly delays.
Government Fees and Costs
- MD5 Manufacturing License: Rs 5,000 per application + Rs 500 per product
- Test License (MD13): Typically included in overall fees
- MD15 Import License: For Class A devices, approx. 50 per product (converted to INR as per prevailing exchange rate)
Additional costs include product testing fees at government labs and notified body audit charges, which vary by organization.
Common Challenges and Solutions
- Incomplete Documentation: Many applicants face delays due to missing or improperly prepared documents. Utilize our templates and checklists to ensure completeness.
- Delays in Product Testing: Testing labs often have backlogs. Book testing slots early and consider multiple approved labs.
- Audit Non-compliance: Prepare thoroughly by conducting internal audits and gap assessments before the notified body visit.
- Regulatory Updates: Stay informed about changes in MDR and notifications to avoid non-compliance. We provide regular updates and advisory services.
Expert Consultation and Support
Navigating CDSCO licensing can be daunting. Our expert team, with over 25 years of experience and a track record of guiding 500+ manufacturers, offers:
- End-to-end application preparation and submission
- Document drafting and review
- Coordination with notified bodies and testing labs
- Audit preparedness and remediation support
- Post-approval compliance management
Engaging experienced consultants can reduce approval timelines by up to 30% and minimize costly rejections.
Getting Started with Your CDSCO License Application
- Assess Device Classification: Confirm Blood Bank Centrifuge as Class A under the latest CDSCO notification.
- Prepare Technical Files: Immediately start compiling Device and Plant Master Files, risk management documentation, and QMS records.
- Apply for Test License (Form MD13): Submit your application on the CDSCO MD Online Portal to initiate testing.
- Plan Product Testing: Schedule testing at approved laboratories to avoid delays.
- Engage a Notified Body: Identify and contract with a notified body early for the audit phase.
- Submit Manufacturing License Application (Form MD3): Once testing and documentation are complete, apply for the MD5 license.
- Prepare for Audit and Queries: Conduct mock audits and prepare responses to regulatory queries proactively.
By following these targeted steps tailored to the Blood Bank Centrifuge, you can confidently navigate the CDSCO licensing process and bring your product to the Indian market efficiently.
For personalized guidance or to begin your application process, contact us today. Our expertise is your fastest route to regulatory success.